Skip to main content

SYSTEMATIC REVIEW article

Front. Med.
Sec. Translational Medicine
Volume 11 - 2024 | doi: 10.3389/fmed.2024.1432455
This article is part of the Research Topic Remedying the injured brain in cognitive impairment: potential neuroimmune communication signaling and therapeutic opportunities View all 3 articles

Research hotspots and trends on NF-κB in cognitive impairment: a bibliometric analysis

Provisionally accepted
Lin Bai Lin Bai 1,2Fangyuan Xu Fangyuan Xu 2Peijia Hu Peijia Hu 1,2Zhiqiang Shen Zhiqiang Shen 1,2Su Xingxing Su Xingxing 1,2Qingqing Wang Qingqing Wang 1,2Hongliang Cheng Hongliang Cheng 1,2*
  • 1 Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui Province, China
  • 2 Anhui University of Chinese Medicine, Hefei, China

The final, formatted version of the article will be published soon.

    Background: Cognitive impairment (CI) endangers the physical and mental health of patients in a significant manner, and it is expected that the number of people with CI in China will rise to 45.33 million by 2050. Therefore, CI has become a popular research topic. Inflammatory damage plays a key role in the pathogenesis of CI, and NF-κB is an important inflammatory signalling pathway. However, no bibliometric analysis regarding the relationship between CI and NF-κB has been reported. Methods: A bibliometric analysis regarding NF-κB and CI from January 1, 2008 to December 12, 2023 was conducted in the Science Citation Index-Expanded of the Web of Science Core Collection. The frontiers, hotspots, and trends of research regarding the role of NF-κB in CI were identified. VOSviewer and CiteSpace were used to analyse the retrieved articles and identify the author, country, institution, and keywords, as well as co-cited authors, co-cited journals, and co-cited references.We analysed 1,468 original articles and reviews. Publications on NF-κB in CI began in 2010 and increased sharply in 2018. Hong Hao was the most represented author, having published19 articles, and Chinese authors published more studies than those from other countries. China Pharmaceutical University published the most papers; however, the USA has a strong influence and demonstrates international cooperation. The keywords "apolipoprotein e" and "therapeutic target" demonstrated strong citation bursts, and this tendency may persist in the upcoming years. Neuroinflammation demonstrated a strong influence in research regarding NF-κB in CI. Gut microbiota and ketogenic diet also play an important role in NF-κB in CI.This bibliometric analysis and visualisation using VOSviewer and CiteSpace reveal that the role of NF-κB in CI has become a research hotspot. The results of this study indicate that "neuroinflammation," "microglial," and "pathway" remain hotspots for future research. However, studies regarding NF-κB in CI have predominantly focused on basic research; future research should be expanded to include therapeutic targets, microbiota, and ketogenic diet.

    Keywords: NF-κB, cognitive impairment, bibliometric analysis, Citespace, VOSviewer

    Received: 14 May 2024; Accepted: 07 Nov 2024.

    Copyright: © 2024 Bai, Xu, Hu, Shen, Xingxing, Wang and Cheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Hongliang Cheng, Anhui University of Chinese Medicine, Hefei, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.